IPO News

Jersey Mike’s leads the pipeline with a potential $1.09 billion NYSE offering, followed by Reformation, Amapá Minerals and Saudi lubricant producer Petrolube. Other notable candidates include Lyntris, AlphaSense, Moonshot AI, AgiBot, TAWAL and Pepkor’s planned fintech spin-off. Together, the transactions span North America, Asia-Pacific, MENA and Africa, reflecting continued demand for sizable public-market opportunities across diverse industries and global markets.

Global IPO activity is accelerating, led by large technology and infrastructure deals. In the U.S., Switch, Anthropic, Holtec, JERA and YPF Electric Energy are pursuing or considering listings. Europe remains mixed, with Utmost and Howden advancing plans while AS Watson may delay. Asia-Pacific is especially active: CXMT has raised $8.6 billion, while Zhongji Innolight, Eoptolink, Shein, AirTrunk, DeepSeek and Kopi Kenangan prepare offerings, though Syngenta’s Hong Kong IPO could slip to 2027. Market conditions and regulatory approvals remain key uncertainties.

Global IPO activity is gaining momentum across the United States, Europe and Asia-Pacific. DuPont Registry, Ennismore, Syntiant and Scribe Therapeutics are advancing U.S. listings, while Digi Spain has priced a €330 million offering at €5.60 per share. In Asia, AI chipmaker Rebellions is targeting a South Korean IPO in 2027, with a possible U.S. ADR to follow. The deals highlight renewed investor appetite across luxury, hospitality, telecom, biotechnology and artificial intelligence sectors amid improving market conditions and stronger global sentiment.

Recent IPO activity shows renewed breadth across U.S. and European markets, with large listings and filings spanning restaurants, consumer retail, fintech, digital infrastructure, defence, telecom and healthcare real estate. In the U.S., Jersey Mike’s, Nutrabolt, iHerb and several Nasdaq debutants highlight stronger investor appetite, while Europe’s pipeline includes KNDS, Dusk, Infracore, Digi Spain and Smag. Although market volatility remains a constraint, IPO momentum appears to be broadening beyond AI-led growth stories and defensive consumer names across public equity markets today.

Global IPO activity remained robust, led by U.S. technology, industrial, mining, insurance, and mobility listings, including OpenAI’s delayed IPO plans, Bending Spoons’ US$1.62bn Nasdaq deal, and Doncasters’ strong debut. Europe saw defense, real estate, retail, and IPO research updates, while Asia-Pacific featured Shenzhen’s record China Resources New Energy IPO, plus Hong Kong and ASX candidates, underscoring broad investor appetite across regions, despite some postponements and withdrawals.

U.S. IPO news included SpaceX’s post-debut pullback, Doncasters’ planned listing at up to a $4.43 billion valuation, Brookfield-backed Csquare’s NYSE filing amid AI infrastructure demand, and renewed SPAC interest. Asia-Pacific activity featured Mynt’s Philippine IPO targeting $1 billion and an $8 billion valuation, MetaX’s planned Hong Kong listing of at least $1 billion, Xiaohongshu’s Hong Kong IPO ambitions, Alebund’s $200 million–$300 million Hong Kong IPO, and Qiandaohu’s $150 million–$200 million caviar IPO pipeline across U.S. and Asia-Pacific markets this week.

IPO activity remains concentrated in the U.S., led by SpaceX, OpenAI, SK Hynix, Bending Spoons, and Kakao Mobility, while biotech names Parabilis and Kardigan show renewed sector momentum. Asia-Pacific listings focus on Hong Kong robotics, AI, parking technology, and an ASX gold spin-off. In MENA, Saudi offerings face weaker sentiment, with Arabian Dyar shelving plans and Mutlaq Al-Ghowairi withdrawing its $800 million IPO, despite Ninja testing appetite for a possible $1 billion deal. Overall, mega deals dominate investor attention globally now.

Global IPO activity is accelerating, led by SpaceX’s planned $75 billion Nasdaq debut and strong demand from Japanese retail investors. AI remains the dominant theme, with Anthropic confidentially filing, OpenAI advancing bank discussions, and ERock, INNIO and Quantinuum drawing investor attention across data-center power and frontier technology. Outside the U.S., Apotex may revive Toronto issuance, Bohus and Magnora expand Oslo listings, Go advances in Tokyo, Anker targets Hong Kong and CANAL+ strengthens its African market presence in Johannesburg this cycle.

Recent IPO activity is led by U.S. listings, with OpenAI preparing a high-profile AI offering and Innio targeting a valuation of up to $20.25 billion on Nasdaq. Entrata, Liftoff, Safepoint, WhiteHawk Minerals, DSC, and Doncasters are also testing investor demand across software, energy, aerospace, and China-linked issuers. In Asia-Pacific, Kunlunxin plans a $1 billion to $2 billion Hong Kong IPO, while Malaysia’s Big Caring seeks up to $750 million, underscoring continued global appetite for sizable new listings in 2026 markets.

Global IPO activity is accelerating across major regions, led by U.S. filings from SpaceX, OpenAI, Oura, Blockchain.com, SB Energy and ERock. Europe is seeing momentum through KNDS’s planned Frankfurt listing, Uzbekistan’s London IPO and Germany’s Uniper sale options, while Asia-Pacific activity includes Dien May Xanh in Vietnam and PCG Power in Hong Kong. Dangote’s planned refinery IPO adds MENA exposure. Themes include AI infrastructure, energy, defense, crypto, health technology and large-scale strategic listings amid renewed investor demand for IPOs worldwide.

U.S. IPO activity accelerated with major AI, infrastructure, energy and fintech listings, led by SpaceX’s planned $75 billion Nasdaq IPO, Cerebras’ $5.55 billion debut, and Blackstone Digital Infrastructure Trust’s $1.75 billion offering. Forbright, Quantinuum, WhiteHawk and Kraken also advanced IPO plans. In Europe, KNDS pressed ahead with a summer IPO while Germany weighed a stake. In Asia-Pacific, Baidu’s Kunlunxin, Cyan Renewables and KK Mart pursued Hong Kong, Singapore-related and Bursa Malaysia listing options, reflecting renewed global investor appetite for issuance.

Global IPO activity is accelerating across major regions, led by large technology, infrastructure, and consumer listings. In the U.S., Blackstone’s data center vehicle, Cerebras, Quantinuum, Lime, Odyssey, Applied Aerospace & Defense, and Tenneco highlight strong demand for AI, quantum, biotech, mobility, defense, and industrial deals. Europe is seeing London IPO plans from Barnes & Noble/Waterstones and Dangote Cement, while Asia-Pacific features major Hong Kong and Tokyo listings from Syngenta, Kunlunxin, Three-Circle, Go, Sany Heavy, and SkinKandy this year overall globally.

Global IPO activity remains active across major regions, led by large U.S. listing plans from SpaceX, Roze AI, SK Hynix, Tenneco and Pershing Square USA. Europe’s pipeline includes delayed or potential listings from RAC, Dolomiti Energia and BioMar, while Singapore is advancing dual U.S.-Singapore listing rules. In MENA, Saudi Arabia’s DABS IPO is testing investor confidence amid volatility, highlighting selective resilience despite a sharp regional slowdown in issuance across the wider GCC market.

A historic tech IPO wave is building, with giants like SpaceX, OpenAI, and Anthropic targeting a combined $3 trillion valuation, signaling a massive shift in public equities. In the U.S., Milan-based Bending Spoons preps a $20 billion listing, while the new Texas Stock Exchange targets a 2027 launch. European markets remain dynamic; Revolut eyes a staggering $200 billion valuation by 2028, and Boots explores a London float. Meanwhile, geopolitical volatility forced telecom operator Digi to postpone its Spanish debut.

Madison Air achieved a blockbuster $15.65 billion NYSE debut, while biotech firm Kailera Therapeutics surged 62%. The pipeline is expanding rapidly, highlighted by AI chipmaker Cerebras targeting a $35 billion valuation alongside major filings from Inspire Brands, Kraken, and EagleRock. As IPOX® experts note, defense tech and software sectors remain robust. Internationally, Syngenta prepares for a massive $10 billion Hong Kong IPO, and Uzbekistan’s sovereign fund secures BlackRock for its upcoming London listing.

The U.S. market braces for potential mega-listings from SpaceX and OpenAI, though IPOX® CEO Josef Schuster cautions that even massive debuts face a strict buyer's market. Meanwhile, the defense "supercycle" fuels momentum for aerospace firms like AEVEX and HawkEye 360. In Europe, TK Elevator explores a €25 billion float alongside Terra Quantum's $3.25 billion SPAC deal. In Asia, Seven & i Holdings has delayed its highly anticipated 7-Eleven spin-off to 2027 amid market uncertainty.

U.S. markets prepare for mega-cap listings, led by SpaceX’s ambitious $75 billion target and Anthropic’s potential $60 billion debut. SK Hynix and Grifols are also eyeing massive U.S. listings, while AI and energy demands propel X-Energy and HMH Holding. As IPOX® CEO Josef Schuster notes, defense and energy IPOs remain exceptionally well-received, highlighted by AEVEX's filing. Globally, Middle Eastern listings face geopolitical delays, while European and Asian markets see renewed activity from Gategroup and Xaircraft.

In the U.S., crypto exchange Kraken has frozen its multibillion-dollar IPO amid challenging market conditions, while Samsonite shareholders approved a strategic dual listing. South America sees Brazilian sanitation firm Aegea targeting a massive $7.8 billion valuation. Meanwhile, Asia-Pacific activity remains robust, highlighted by ByteDance-backed Dongchedi's planned $1.5 billion Hong Kong debut and a groundbreaking new partnership between Nasdaq and SGX to establish a unified Global Listing Board.

SpaceX, the rocket manufacturer founded by Elon Musk, is considering a megacap Nasdaq IPO that could value the company at a staggering $1.75 trillion. A listing could occur by June 2026 if the firm secures early inclusion in the Nasdaq 100 index. Meanwhile, Japanese digital payment giant PayPay, backed by SoftBank, successfully debuted on the Nasdaq with a $12.1 billion valuation. IPOX® CEO Josef Schuster noted the company’s unique opportunity to fill a market void despite structural concerns.

The global IPO market is currently heating up with several blockbuster listings in the pipeline. SpaceX is preparing for a record-breaking $50 billion public offering, recently adding Citigroup to its underwriter lineup. In the consumer sector, Roark Capital is weighing a $2 billion IPO for Inspire Brands, the owner of Dunkin'. Meanwhile, Europe anticipates a major boost to the London Stock Exchange as Oaktree Capital Management selects banks for a £2.5 billion listing of wealth management provider Utmost Group Plc.

Elon Musk’s SpaceX is reportedly preparing to confidentially file for a U.S. initial public offering as early as March, aiming for a record-breaking June listing. This highly anticipated share sale could raise up to $50 billion and command a staggering valuation exceeding $1.75 trillion, bolstered by its recent acquisition of the artificial intelligence startup xAI. SpaceX has already aligned major financial institutions, including Bank of America, Goldman Sachs, JPMorgan, and Morgan Stanley, to lead this historic, market-defining public market debut.

The U.S. IPO market faces headwinds as Clear Street and Liftoff Mobile withdraw their listings. IPOX® Associate Lukas Muehlbauer and IPOX® VP Kat Liu noted that AI-driven volatility and crypto declines forced these moves to avoid "failed" IPO stigmas. Meanwhile, Bain Capital explores a $3 billion IPO for Dessert Holdings. In Europe, Thyssenkrupp plans a $13.5 billion materials spin-off, while UI Boustead REIT preps a $788 million Singapore float.

Goldman Sachs predicts a historic $160 billion U.S. IPO boom in 2026, though market volatility is currently testing recent listings. ARKO Petroleum debuted softly at an $808 million valuation, with IPOX® VP Kat Liu noting investors are "approaching deals with caution." Consequently, Clear Street and Agibank recently downsized or postponed their offerings. Globally, mega-deals continue to advance as DayOne targets a $20 billion U.S. listing and PayPay files for $1.5 billion. Meanwhile, IPOX® Associate Lukas Muehlbauer warns of volatility risks amid Saudi Arabia’s retail IPO push.

Nvidia eyes a stake in OpenAI ahead of IPO. IPOX® Associate Lukas Muehlbauer highlights the strength of defense listings following York Space Systems’ $4.75 billion debut, though software volatility forces Liftoff Mobile and Visma to delay. Globally, Syngenta targets a $10 billion Hong Kong deal. Meanwhile, IPOX® CEO Josef Schuster warns on celebrity IPOs, and IPOX® VP Kat Liu analyzes tariff risks for Bob’s Discount Furniture.

SpaceX dominates headlines with a potential $1.5 trillion IPO and xAI merger. Defense firm York Space Systems debuts at $4.75 billion, with IPOX® Associate Lukas Muehlbauer noting the sector’s strength. Muehlbauer also analyzes AI infrastructure play Forgent Power and biotech Eikon Therapeutics. IPOX® VP Kat Liu discusses tariff risks for Bob's Discount Furniture, while IPOX® CEO Josef Schuster warns against celebrity-backed listings. Elsewhere, software firm Anaplan preps a return, and JD.com’s property arm files in Hong Kong.

SpaceX accelerates blockbuster IPO plans by lining up four Wall Street banks, while construction tech firm EquipmentShare hits a $7.2 billion valuation in its Nasdaq debut. IPOX® Associate Lukas Muehlbauer analyzes the deal and crypto custodian BitGo’s volatile start as a 2026 bellwether. The U.S. pipeline grows with filings from prime broker Clear Street and Brazilian fintech Agibank, plus potential moves by Jersey Mike’s and Ledger. Globally, European tank maker KNDS prepares a €25 billion listing, and Alibaba’s chip unit explores a spin-off.

The U.S. IPO pipeline accelerates as construction tech firm EquipmentShare targets a $6.4 billion valuation, with IPOX® VP Kat Liu highlighting its "narrative premium." Crypto custodian BitGo eyes a $2 billion debut, drawing commentary from IPOX® CEO Josef Schuster and Associate Lukas Muehlbauer on market selectivity. Brazilian fintech Agibank files for a $1 billion listing. Globally, Czech defense giant CSG launches a massive €30 billion IPO, while Chinese chipmaker Montage Technology preps a $22 billion Hong Kong debut.

Aktis Oncology surges 24% in the first major biotech IPO of 2026, with IPOX® Associate Lukas Muehlbauer highlighting its strategic backing. The U.S. pipeline accelerates as chat platform Discord and fitness app Strava confidentially file for listings, while President Trump weighs a massive Fannie Mae and Freddie Mac public offering. Additionally, Brazilian fintech PicPay files for a $500 million Nasdaq debut, signaling a robust return of large-cap issuers to the market.

In Europe, Octopus Energy spins off its tech arm Kraken at an $8.7 billion valuation to prepare for a future listing. Asia sees a surge in activity as VinFast affiliate GSM targets a massive $20 billion international IPO. Meanwhile, Chinese tech listings accelerate with Alibaba-backed AI unicorn MiniMax launching its $600 million Hong Kong debut and Baidu’s chip unit Kunlunxin filing for a spin-off, while regulators ease rules for rocket firms like LandSpace.

Bill Ackman proposes a unique SpaceX merger, while Medtronic’s MiniMed and fleet AI firm Motive Technologies file for U.S. debuts. SoftBank delays its PayPay IPO to prioritize OpenAI funding, while China’s LandSpace and pet care group Ringpai advance listing plans. In Europe, Visma expands its syndicate for a blockbuster London deal, and Aegea files to break Brazil’s four-year IPO drought, as Seven & i accelerates its U.S. turnaround.